82 related articles for article (PubMed ID: 15664329)
1. High-performance liquid chromatography measurement of hyperforin and its reduced derivatives in rodent plasma.
Rozio M; Fracasso C; Riva A; Morazzoni P; Caccia S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):21-7. PubMed ID: 15664329
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of hypericin and hyperforin in human plasma with liquid chromatography-tandem mass spectrometry.
Riedel KD; Rieger K; Martin-Facklam M; Mikus G; Haefeli WE; Burhenne J
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):27-33. PubMed ID: 15556512
[TBL] [Abstract][Full Text] [Related]
3. Single-drop liquid-phase microextraction for the determination of hypericin, pseudohypericin and hyperforin in biological fluids by high performance liquid chromatography.
Gioti EM; Skalkos DC; Fiamegos YC; Stalikas CD
J Chromatogr A; 2005 Nov; 1093(1-2):1-10. PubMed ID: 16233865
[TBL] [Abstract][Full Text] [Related]
4. Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection.
Bauer S; Störmer E; Graubaum HJ; Roots I
J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):29-35. PubMed ID: 11817306
[TBL] [Abstract][Full Text] [Related]
5. Determination of hyperforin in mouse brain by high-performance liquid chromatography/tandem mass spectrometry.
Keller JH; Karas M; Müller WE; Volmer DA; Eckert GP; Tawab MA; Blume HH; Dingermann T; Schubert-Zsilavecz M
Anal Chem; 2003 Nov; 75(22):6084-8. PubMed ID: 14615985
[TBL] [Abstract][Full Text] [Related]
6. Determination of hyperforin in human plasma using solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
Cui Y; Gurley B; Ang CY; Leakey J
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):129-35. PubMed ID: 12383488
[TBL] [Abstract][Full Text] [Related]
7. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
Biber A; Fischer H; Römer A; Chatterjee SS
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():36-43. PubMed ID: 9684946
[TBL] [Abstract][Full Text] [Related]
8. Variation of hyperforin in Hypericum montbretii during its phenological cycle.
Cirak C; Radusiene J
Nat Prod Res; 2007 Nov; 21(13):1151-6. PubMed ID: 17987494
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis.
Martínez-Poveda B; Verotta L; Bombardelli E; Quesada AR; Medina MA
PLoS One; 2010 Mar; 5(3):e9558. PubMed ID: 20224821
[TBL] [Abstract][Full Text] [Related]
10. Development of a high-performance liquid chromatographic method with electrochemical detection for the determination of hyperforin.
Rückert U; Eggenreich K; Wintersteiger R; Wurglics M; Likussar W; Michelitsch A
J Chromatogr A; 2004 Jul; 1041(1-2):181-5. PubMed ID: 15281267
[TBL] [Abstract][Full Text] [Related]
11. Air/light-free hyphenated extraction/analysis system: supercritical fluid extraction on-line coupled with liquid chromatography-UV absorbance/electrospray mass spectrometry for the determination of hyperforin and its degradation products in Hypericum pertoratum.
Wang Z; Ashraf-Khorassani M; Taylor LT
Anal Chem; 2004 Nov; 76(22):6771-6. PubMed ID: 15538802
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
Schulz HU; Schürer M; Bässler D; Weiser D
Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160
[TBL] [Abstract][Full Text] [Related]
13. Structural investigations of isomeric oxidised forms of hyperforin by HPLC-NMR and HPLC-MSn.
Wolfender JL; Verotta L; Belvisi L; Fuzzati N; Hostettmann K
Phytochem Anal; 2003; 14(5):290-7. PubMed ID: 14516001
[TBL] [Abstract][Full Text] [Related]
14. Fast high-performance liquid chromatographic analysis of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts.
Tolonen A; Hohtola A; Jalonen J
Phytochem Anal; 2003; 14(5):306-9. PubMed ID: 14516003
[TBL] [Abstract][Full Text] [Related]
15. Brain Uptake of Tetrahydrohyperforin and Potential Metabolites after Repeated Dosing in Mice.
Fracasso C; Bagnati R; Passoni A; Guiso G; Cantoni L; Riva A; Morazzoni P; Gobbi M
J Nat Prod; 2015 Aug; 78(8):2029-35. PubMed ID: 26287496
[TBL] [Abstract][Full Text] [Related]
16. Determination of phloroglucinol in human plasma by gas chromatography-mass spectrometry.
Lartigue-Mattei C; Lauro-Marty C; Bastide M; Berger JA; Chabard JL; Goutay E; Aiache JM
J Chromatogr; 1993 Jul; 617(1):140-6. PubMed ID: 8376528
[TBL] [Abstract][Full Text] [Related]
17. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
Schulz HU; Schürer M; Bässler D; Weiser D
Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
[TBL] [Abstract][Full Text] [Related]
18. Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology.
Agrosi M; Mischiatti S; Harrasser PC; Savio D
Phytomedicine; 2000 Dec; 7(6):455-62. PubMed ID: 11194173
[TBL] [Abstract][Full Text] [Related]
19. Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agent.
Gartner M; Müller T; Simon JC; Giannis A; Sleeman JP
Chembiochem; 2005 Jan; 6(1):171-7. PubMed ID: 15593112
[TBL] [Abstract][Full Text] [Related]
20. Anticancer and Antibacterial Activity of Hyperforin and Its Derivatives.
Pia Schiavone BI; Verotta L; Rosato A; Marilena M; Gibbons S; Bombardelli E; Franchini C; Corbo F
Anticancer Agents Med Chem; 2014; 14(10):1397-1401. PubMed ID: 25173557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
